AHG Akso Health Group Annual reports only
Services-Business Services, NEC · Nasdaq · SEC CIK 1702318 · Fiscal year ends 03/31
Financial factors as of 2026-03-31 (FY2026), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-6.4%
TTM net income YoY86.2%
TTM EPS YoY-93.8%
Revenue 3-yr CAGR1.6%
Net income 3-yr CAGR—
Margins
Gross margin-0.1%
Operating margin-149.7%
Net margin-135.0%
FCF margin-92.5%
EBITDA margin-132.5%
Returns
ROE-9.8%
ROA-9.2%
ROIC (approx.)-16.1%
Asset turnover0.07x
Leverage & solvency
Liabilities / assets4.6%
Debt / equity0.00x
Current ratio21.77x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.69x
Accruals ratio-2.9%
Payout ratio—
Capex / revenue0.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 |
|---|---|---|
| Income statement | ||
| Revenue | $13.83M | $14.78M |
| Cost of revenue | $13.84M | $15.06M |
| Gross profit | -$11,315 | -$281,526 |
| SG&A expense | $3.99M | $3.64M |
| Operating income | -$20.70M | -$166.30M |
| Pretax income | -$20.70M | -$166.27M |
| Income tax | -$1.99M | -$30.80M |
| Net income | -$18.67M | -$134.98M |
| EBITDA | -$18.33M | -$164.15M |
| EPS (basic) | 0.01 | 0.16 |
| EPS (diluted) | 0.01 | 0.16 |
| Weighted avg. shares (diluted) | 2.17B | 855.29M |
| Balance sheet | ||
| Cash & equivalents | $170,572 | $176.23M |
| Receivables | $1.28M | $954,200 |
| Inventory | $200,135 | $190,242 |
| Current assets | $189.55M | $196.12M |
| PP&E, net | $12,015 | $16,148 |
| Goodwill | — | $10.83M |
| Intangibles | $58,319 | $7.88M |
| Total assets | $189.63M | $214.95M |
| Current liabilities | $8.71M | $13.81M |
| Total liabilities | $8.71M | $15.80M |
| Shareholders' equity | $180.93M | $199.12M |
| Shares outstanding | — | 1.66B |
| Cash flow statement | ||
| Operating cash flow | -$12.79M | $1.18M |
| Capital expenditure | $1,638 | $154,460 |
| Free cash flow | -$12.79M | $1.02M |
| Investing cash flow | -$163.46M | -$105.91M |
| Financing cash flow | $350,000 | $195.88M |
| Depreciation & amortization | $2.37M | $2.15M |
Free plan shows the latest 2 periods; Pro shows all 11 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.